
Human Microbiome in Health and Disease - Part A
- 1st Edition, Volume 191 - September 26, 2022
- Editors: Bhabatosh Das, Vijai Singh
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 9 9 7 8 6 - 7
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 9 7 8 7 - 4
Human Microbiome in Health and Disease, Volume 191, Part A presents updated knowledge on human microbiome as covered by renowned science faculty across the globe. Chapters… Read more

Human Microbiome in Health and Disease, Volume 191, Part A presents updated knowledge on human microbiome as covered by renowned science faculty across the globe. Chapters in this volume include an introduction to human microbiome, Structure, functions and diversity of healthy human microbiome, Role of human microbiome in cancer, Gut microbiota and gastrointestinal cancer, Dysbiosis of human microbiome and metabolic diseases, Gut microbiome and type 2 diabetes, Gut microbiome and non-alcoholic fatty liver disease, Hepatic drug metabolism and intestinal microbiota, Emerging tools for understanding the human microbiome, and Microbiome therapeutics: Opportunity and challenges, and more.
These chapters cover the composition, diversity, dynamics and functions of human microbiome in health and disease. This book will form an excellent and informative text on keystone, autochthonous, and exogenous microbiota important for human health in a simple to understand and easy to read format.
- Covers the structure, functions and diversity of human microbiome in health and disease
- Includes discussions on drug metabolisms and microbiome based therapeutics
- Presents emerging tools for understanding the human microbiome
Basic researchers, Clinicians, Pharmacologists, Graduate students
Preface
Bhabatosh Das and Vijai Singh
1. An introduction to human microbiome
Bhabatosh Das
2. Emerging tools for understanding the human microbiome
Tarini Shankar Ghosh and Mrinmoy Das
3. Structure, functions, and diversity of the healthy human microbiome
Taruna Ahrodia, Santanu Das, Susmita Bakshi and Bhabatosh Das
4. An overview of cancer and the human microbiome
Soumendu Mahapatra, Smrutishree Mohanty, Rasmita Mishra and Punit Prasad
5. Gut microbiota in gastrointestinal diseases
Gargi Bhattacherjee, Khushal Khambhati, Nisarg Gohil, Priyanka Singh, Jigresh Gohil, Bijun Snehi, Rupesh Maurya, Dinh-Toi Chu, Suresh Ramakrishna and Vijai Singh
6. Gut dysbiosis and metabolic diseases
Purbita Bandopadhyay and Dipyaman Ganguly
7. Gut microbiome and type 2 diabetes
Sweta Patel, Sriram Seshadri and Sarat Dalai
8. Gut microbiome and non-alcoholic fatty liver disease
Ayushi Purohit, Md Jahangir Alam, Bharti Kandiyal, Shalimar, Bhabatosh Das and Sanjay K. Banerjee
9. Hepatic drug metabolism and gut microbiome
Tanshi Mehrotra and Subir Kumar Maulik
10. Microbiome-based therapeutics: Opportunity and challenges
Archana Pant and Bhabatosh Das
- Edition: 1
- Volume: 191
- Published: September 26, 2022
- Language: English
BD
Bhabatosh Das
VS
Vijai Singh
Prof. Vijai Singh is currently serving as Head of the Department of Biosciences, School of Science and Dean (Research & Innovation) at Indrashil University, Rajpur, Mehsana, India. Prior to this, he held the position of Associate Professor in the same department at Indrashil University. He has also served as Assistant Professor in the Department of Biological Sciences and Biotechnology at the Institute of Advanced Research, Gandhinagar, and in the Department of Biotechnology at the Invertis University, Bareilly, India. Earlier of his career, Prof. Singh worked as a Postdoctoral Fellow in the Synthetic Biology Group at the Institute of Systems and Synthetic Biology, Paris, France and at the School of Energy & Chemical Engineering at the Ulsan National Institute of Science and Technology, Ulsan, South Korea. He earned his Ph.D. in Biotechnology in 2009 from the ICAR-National Bureau of Fish Genetic Resources, Uttar Pradesh Technical University, Lucknow, India. His doctoral research focused on the development of molecular and immunoassays for the diagnosis of Aeromonas hydrophila. Prof. Singh’s research interests lies in the design and construction of novel biosynthetic pathways for production of medically and industrially important biomolecules. His laboratory is also actively engaged in developing CRISPR-Cas systems for gene knock out, knock in, gene regulation and diagnostic. With over 15 years of research and teaching experience, his areas of expertise include synthetic biology, metabolic engineering, bioinformatics, microbiology, and industrial microbiology. He has an extensive academic record, with over 110 articles, 89 book chapters, 26 books and 3 patents to his credits. Prof. Singh has received number of prestigious awards, including the Bioclues Innovation, Research and Development Award (2023) from the BIOCLUES Society, the Vice Chancellor's Best Research Award (2023) from Indrashil University, and the Agathiyar Chemical Biology Award (2023) from the Society of Chemical and Synthetic Biology. At Indrashil University, he currently serves as chairman of the Board of Study, and is a member of the Academic Council of Indrashil University. He also holds the position of the Member Secretary of the Institutional Biosafety Committee (IBSC) at the university. Dr. Singh is actively involved in national and international scientific advisory roles.